Optimal medical therapy scores, discharge prescribing, and readmissions data can help pharmacists demonstrate the value of heart failure services.
|Videos|March 23, 2018
The Expanding Role of Pharmacy Technicians
In Idaho, pharmacists are able to delegate tasks, such as final product verification, transferring prescriptions, and even administering vaccines, to pharmacy technicians.
Advertisement
In this clip, Alex J. Adams, PharmD, MPH, from the Idaho State Board of Pharmacy, discusses why expanding the role of pharmacy technicians improves workflow efficiencies and benefits the pharmacy team as a whole. In Idaho, pharmacists are able to delegate tasks, such as final product verification, transferring prescriptions, and even administering vaccines, to pharmacy technicians.
Advertisement
Related to this article
Post hoc AHA 2026 data show the oral GLP-1 receptor agonist lowered systolic blood pressure across hypertension stages, partly beyond weight loss.
Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
Orforglipron Lowers Systolic BP in ATTAIN-1, ATTAIN-2 Analyses
3
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
4
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
5